A carregar...

Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I

Myotonic dystrophy Type I (DM1) is an autosomal dominant multi-system disorder characterized by myotonia and muscle weakness. Type 2 diabetes (T2D) and cancer have been shown to be part of the DM1 phenotype. Metformin, a well-established agent for the management of T2D, is thought to have cancer-pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Alsaggaf, Rotana, Pfeiffer, Ruth M., Wang, Youjin, St. George, Diane Marie M., Zhan, Min, Wagner, Kathryn R., Amr, Sania, Greene, Mark H., Gadalla, Shahinaz M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336337/
https://ncbi.nlm.nih.gov/pubmed/31749144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32801
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!